International Journal of Mycobacteriology
Overview
International Journal of Mycobacteriology is a scientific journal, published since 2012 in English. The journal's country of origin is India and its primary focus areas are microbiology and infectious diseases.
Details
Details
Abbr.
Int J Mycobacteriol
Start
2012
End
Continuing
Frequency
Quarterly
p-ISSN
2212-5531
e-ISSN
2212-554X
Country
India
Language
English
Specialties
Microbiology
Infectious Diseases
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 10631
29
SJR / Ranks: 10704
379
CiteScore / Ranks: 10255
2.20
Recent Articles
11.
Pokam B, Shindoh E, Djuikoue C, Nana C, Kakah S, Elisee A, et al.
Int J Mycobacteriol
. 2024 Dec;
13(4):387-393.
PMID: 39700160
Background: Tuberculosis (TB) caused by Mycobacterium tuberculosis is an infectious disease affecting mainly the lungs and persists as the leading cause of death worldwide. With the emergence of coronavirus disease-19...
12.
Kadi C, Najimi N, El Fakihi S, El Allam A, Akil E, Mtili N, et al.
Int J Mycobacteriol
. 2024 Dec;
13(4):379-386.
PMID: 39700159
Background: In Morocco, latent tuberculosis infection (LTBI) is a public health concern affected by the country's location as transit area between sub-Saharan Africa with high TB burden to Europe. This...
13.
Pathak M, Pandya K, Ramwani S, Pingalsur A, Karatela S, Sisodia J, et al.
Int J Mycobacteriol
. 2024 Dec;
13(4):369-378.
PMID: 39700158
Background: Extrapulmonary tuberculosis (EP-TB) constitutes one-fifth of all tuberculosis (TB) cases. EP-TB mimics common infections which pose diagnostic dilemma, requires extensive diagnostics that culminate into therapeutic delay often resulting in...
14.
Daka S, Ota M, Samungole G
Int J Mycobacteriol
. 2024 Dec;
13(4):362-368.
PMID: 39700157
Background: This study aims to identify the factors associated with favorable treatment outcomes of tuberculosis (TB) patients registered at two hospitals and two urban health centers in Lusaka, Zambia in...
15.
Farnia P, Maleknia M, Farnia P, Ghanavi J
Int J Mycobacteriol
. 2024 Dec;
13(4):355-361.
PMID: 39700156
This review examines the impact of F420 biosynthesis protein C (fbiC) mutations in Mycobacterium tuberculosis (Mtb) and their influence on the bacterium's dormancy mechanisms. The potential role of fbiC mutations...
16.
Vahabi M, Bostanci A, Tasbakan S, Karaarslan I, Cavusoglu C, Tasbakan M
Int J Mycobacteriol
. 2024 Sep;
13(3):351-353.
PMID: 39277899
Bacteria other than Mycobacterium tuberculosis and Mycobacterium leprae are known as nontuberculous mycobacteria (NTM), and the frequency of clinically symptomatic forms is increasing day by day. Mycobacterium fortuitum, a rapidly...
17.
Ahmad T, Zyoud S, Murad M, Baig M
Int J Mycobacteriol
. 2024 Sep;
13(3):337-350.
PMID: 39277898
Background: The number of tuberculosis (TB)-related morbidities and mortalities is still high in the South-east Asian region. This study was performed to characterize and visualize the post-coronavirus disease 2019 (COVID-19)...
18.
Sengupta S, Jain P, Ratnam R, Pandey B, Singh U, Kumar V, et al.
Int J Mycobacteriol
. 2024 Sep;
13(3):331-336.
PMID: 39277897
Background: Phenotypic drug susceptibility testing (DST) is considered the gold standard for detecting linezolid (LZD) resistance in Mycobacterium tuberculosis (MTB), but it is time-consuming. Nanopore sequencing offers a potentially faster...
19.
Ayoubi S, Farnia P, Farnia P, Ghanavi J, Velayati A
Int J Mycobacteriol
. 2024 Sep;
13(3):320-330.
PMID: 39277896
Background: Multidrug-resistant tuberculosis (MDR-TB) is a serious threat to global tuberculosis (TB) control efforts. This study aims to investigate the trend of MDR-TB prevalence in Iran over 20 years. Methods:...
20.
Seddighi A, Seddighi A, Zali A
Int J Mycobacteriol
. 2024 Sep;
13(3):314-319.
PMID: 39277895
Background: Tuberculosis (TB) remains a significant global health concern, with extrapulmonary manifestations, including central nervous system involvement, posing substantial morbidity and mortality. While medical treatment with anti-TB drugs is the...